- Published at
- by globenewswire.com
mixed
mixed
News for Amoy Diagnostics Co., Ltd. (300685.SZ)
- Published at
- by globenewswire.com
mixedmixedCompanion Diagnostics Market Anticipated To Grow At 12.5% CAGR, Reaching USD 26.0 Billion By 2033 | Dimension Market Research
Advancements and Projections in the Companion Diagnostic Market: Insights, Trends, Opportunities, and Recent Developments...- Published at
- by globenewswire.com
positivepositiveGene Fusion Testing Market is estimated to be US$ 794.0 million by 2032 and is anticipated to register a CAGR of 12.5%– By PMI
Gene Fusion Testing Market (2022 – 2032) Research Report Analysis and Outlook Insights | PDF | 170 No of pages .The Gene Fusion Testing Market research...- Published at
- by prnewswire.com
positivepositiveGene Fusion Testing Market's Evolution: Emerging Technologies and Clinical Impact Unveiled
/PRNewswire/ -- The "Gene Fusion Testing Market - A Global and Regional Analysis: Focus on by Category, Technology, Indication, End User, and Region - Analysis...- Published at
- by prnewswire.com
mixedmixedThe Companion Diagnostics Market size to grow at a CAGR of 22.59% from 2022 to 2027|Rising use of personalized medicine to boost market growth - Technavio
/PRNewswire/ -- The companion diagnostics market is estimated to grow at a CAGR of 22.59% between 2022 and 2027. The market size is forecast to increase by USD...- Published at
- by prnewswire.com
mixedmixedMolecular Diagnostics Market worth $28.6 billion | MarketsandMarkets
/PRNewswire/ -- The molecular diagnostics industry is poised to undergo significant advancements in the near future, fueled by rapid technological innovation...- Published at
- by prnewswire.com
mixedmixedGlobal Companion Diagnostics Technologies and Markets Report 2023-2027 Featuring Bio-Rad, Illumina, Foundation Medicine, Myriad Genetics, F. Hoffmann-La Roche, Qiagen, and Thermo Fisher Scientific
/PRNewswire/ -- The- Published at
- by prnewswire.com
mixedmixedGlobal Hemato Oncology Testing Market to 2027: Increasing Incidence of Hematologic Cancer Drives Growth
/PRNewswire/ -- The "Hemato Oncology Testing Market by Product & Services (Services, Assay Kits), Cancer (Leukemia (Acute Myeloid, Acute Lymphocytic), Lymphoma...- Published at
- by globenewswire.com
mixedmixedCancer Diagnostics Market to Reach USD 300.79 Billion by 2031 | Latest InsightAce Study
Companies covered in this study are GE Healthcare, Abbott Laboratories, Hologic Inc., Agilent Technologies Inc., Roche Diagnostics, FUJIFILM Corporation,...TMO.MXTMORYLPFQIAN.MXQIA.DEQGENQDEL.MXQDELPHIAN.MXPHIA.DEPHIA.ASPHI1.DEPHG.BAPHGPFED.BAPFECL.SNPFE.SNPFE.MXPFE.DEPFENVSN.MXNVSEFNVSD.BANVSNOVN.SWN1VS34.SAMYGNMYD.DEILU.DEILMN.MXILMNI1LM34.SAHOLX.MXHOLXHO1.DEH1OL34.SADSRLFDIA.MIDHR.MXDHRDHER34.SADGX.MXDGXDAP.DE0R2B.L0R0H.L0KSX.L0K9E.L0K3W.L0J8Z.L0J5Q.L0A55.LBRM.DEBMYB34.SABMY.MXBMY.BABMYALPMYALPMFABTCL.SNABT.SNABTA1GI34.SAA.MXA4503N.MX300685.SZ0HAV.L- Published at
- by marketscreener.com
negativenegativeGlobalData : AmoyDx new PCR-based PLC panel to expand diagnosis, treatment options of NSCLC patients in Japan, says GlobalData
10 Apr, 2023 AmoyDx new PCR-based PLC panel to expand diagnosis, treatment options of NSCLC patients in Japan, says GlobalData Share ... | April 11, 2023- Published at
- by globenewswire.com
mixedmixedMolecular Diagnostics Market Size worth USD 46.65 Billion with Registering a CAGR of 12.8% by 2029, Size, Share, Demand, Rising Trends and Competitive Outlook
Molecular Diagnostics Market was valued at USD 17.8 billion in 2021 and is expected to reach USD 46.65 billion by 2029, registering a CAGR of 12.8% during...- Published at
- by prnewswire.com
mixedmixedWorldwide In Vitro Diagnostic Tests Market Report 2022: COVID-19 Impacts, Summary, Regions of Market Influence, and What to Watch For Long-Term
/PRNewswire/ -- The- Published at
- by prnewswire.com
mixedmixedWorldwide In Vitro Diagnostic Tests Market Report 2021 with 200+ Company profiles
/PRNewswire/ -- TheTMO.MXTMOSSMXYSSMXFQDEL.MXQDELBMRABDXBBDX.MXBDXAXDX.MXAXDXANPCYANPCFAGL.L6869.T300685.SZ0R19.L0R0H.L0H8E.L0A55.LVNRXTRIBTECHT1CH34.SARNVAWRNVADRNVAQIAN.MXQIA.DEQGENPKIP1KI34.SAOPGNNMRDMYGNMYD.DEHOLX.MXHOLXHO1.DEH1OL34.SAGRFSGRFPN.MXGRF.MCGIKLYGIFOFGIFLFGH.MXGHFMIERBEPGNYEPGNFEKF.LEKDHFECX.DEDSRLFDIA.MICDNABUWA.DEBRKR.MXBRKRBIOCBIO-BBIO4549.T0KHE.L0K3W.L0J5Q.L0A8L.LVIVOVCYTMDTN.MXMDT.BAMDTLMNXDXCM.MXDXCMDHR.MXDHRDHER34.SADC4.DEDAP.DED1EX34.SACERS2M6.DE0Y6X.L0R2B.L0K0K.L0A4M.L- Published at
- by prnewswire.com
neutralneutral- Published at
- by thestreet.com
mixedmixedWorldwide Next-Generation Sequencing Industry To 2025 - Key Drivers And Trends
DUBLIN, June 14, 2021 /PRNewswire/ -- The "Next-Generation Sequencing: Emerging Clinical Applications and Global Markets 2020-2025" report has been added toILU.DEILMN.MXILMNI1LM34.SAHTGMGH.MXGH0J8Z.LYGEN.LTMO.MXTMOTKBIFRYLPFROGN.MXROG.SWRO.SWRHHVFRHHBYRHHBFPSNLPHIAN.MXPHIA.DEPHIA.ASPHI1.DEPHG.BAPHGPACBONC.LNTRANSTGMYGNMYD.DEIDXGIDGGWFLGT.MXFLGTEPGNYEPGNFECX.DECGIXCDNAA1GI34.SAA.MXA688315.SS4974.T0TDF.L0R0H.L0QQ6.L0K3W.L0HAV.L084650.KQ038290.KQBIOCBDSXANPCYANPCFAGL.L300685.SZ000710.SZ- Published at
- by prnewswire.com
mixedmixedWorldwide Next-Generation Sequencing Industry to 2025 - Key Drivers and Trends
/PRNewswire/ -- TheILU.DEILMN.MXILMNI1LM34.SAHTGMGH.MXGH0J8Z.LYGEN.LTMO.MXTMOTKBIFRYLPFROGN.MXROG.SWRO.SWRHHVFRHHBYRHHBFPSNLPHIAN.MXPHIA.DEPHIA.ASPHI1.DEPHG.BAPHGPACBONC.LNTRANSTGMYGNMYD.DEIDXGIDGGWFLGT.MXFLGTEPGNYEPGNFECX.DECGIXCDNAA1GI34.SAA.MXA688315.SS4974.T0TDF.L0R0H.L0QQ6.L0K3W.L0HAV.L084650.KQ038290.KQBIOCBDSXANPCYANPCFAGL.L300685.SZ000710.SZ